Cargando…

Pyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes

BACKGROUND: Endogenous defense against oxidative stress is controlled by nuclear factor erythroid 2-related factor 2 (Nrf2). The normal compensatory mechanisms to combat oxidative stress appear to be insufficient to protect against the prolonged exposure to reactive oxygen species during disease. Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Liddell, Jeffrey R., Lehtonen, Sarka, Duncan, Clare, Keksa-Goldsteine, Velta, Levonen, Anna-Liisa, Goldsteins, Gundars, Malm, Tarja, White, Anthony R., Koistinaho, Jari, Kanninen, Katja M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768425/
https://www.ncbi.nlm.nih.gov/pubmed/26920699
http://dx.doi.org/10.1186/s12974-016-0515-9
_version_ 1782417947381202944
author Liddell, Jeffrey R.
Lehtonen, Sarka
Duncan, Clare
Keksa-Goldsteine, Velta
Levonen, Anna-Liisa
Goldsteins, Gundars
Malm, Tarja
White, Anthony R.
Koistinaho, Jari
Kanninen, Katja M.
author_facet Liddell, Jeffrey R.
Lehtonen, Sarka
Duncan, Clare
Keksa-Goldsteine, Velta
Levonen, Anna-Liisa
Goldsteins, Gundars
Malm, Tarja
White, Anthony R.
Koistinaho, Jari
Kanninen, Katja M.
author_sort Liddell, Jeffrey R.
collection PubMed
description BACKGROUND: Endogenous defense against oxidative stress is controlled by nuclear factor erythroid 2-related factor 2 (Nrf2). The normal compensatory mechanisms to combat oxidative stress appear to be insufficient to protect against the prolonged exposure to reactive oxygen species during disease. Counterbalancing the effects of oxidative stress by up-regulation of Nrf2 signaling has been shown to be effective in various disease models where oxidative stress is implicated, including Alzheimer’s disease. Stimulation of Nrf2 signaling by small-molecule activators is an appealing strategy to up-regulate the endogenous defense mechanisms of cells. METHODS: Here, we investigate Nrf2 induction by the metal chelator and known nuclear factor-κB inhibitor pyrrolidine dithiocarbamate (PDTC) in cultured astrocytes and neurons, and mouse brain. Nrf2 induction is further examined in cultures co-treated with PDTC and kinase inhibitors or amyloid-beta, and in Nrf2-deficient cultures. RESULTS: We show that PDTC is a potent inducer of Nrf2 signaling specifically in astrocytes and demonstrate the critical role of Nrf2 in PDTC-mediated protection against oxidative stress. This induction appears to be regulated by both Keap1 and glycogen synthase kinase 3β. Furthermore, the presence of amyloid-beta magnifies PDTC-mediated induction of endogenous protective mechanisms, therefore suggesting that PDTC may be an effective Nrf2 inducer in the context of Alzheimer’s disease. Finally, we show that PDTC increases brain copper content and glial expression of heme oxygenase-1, and decreases lipid peroxidation in vivo, promoting a more antioxidative environment. CONCLUSIONS: PDTC activates Nrf2 and its antioxidative targets in astrocytes but not neurons. These effects may contribute to the neuroprotection observed for PDTC in models of Alzheimer’s disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0515-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4768425
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47684252016-02-27 Pyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes Liddell, Jeffrey R. Lehtonen, Sarka Duncan, Clare Keksa-Goldsteine, Velta Levonen, Anna-Liisa Goldsteins, Gundars Malm, Tarja White, Anthony R. Koistinaho, Jari Kanninen, Katja M. J Neuroinflammation Research BACKGROUND: Endogenous defense against oxidative stress is controlled by nuclear factor erythroid 2-related factor 2 (Nrf2). The normal compensatory mechanisms to combat oxidative stress appear to be insufficient to protect against the prolonged exposure to reactive oxygen species during disease. Counterbalancing the effects of oxidative stress by up-regulation of Nrf2 signaling has been shown to be effective in various disease models where oxidative stress is implicated, including Alzheimer’s disease. Stimulation of Nrf2 signaling by small-molecule activators is an appealing strategy to up-regulate the endogenous defense mechanisms of cells. METHODS: Here, we investigate Nrf2 induction by the metal chelator and known nuclear factor-κB inhibitor pyrrolidine dithiocarbamate (PDTC) in cultured astrocytes and neurons, and mouse brain. Nrf2 induction is further examined in cultures co-treated with PDTC and kinase inhibitors or amyloid-beta, and in Nrf2-deficient cultures. RESULTS: We show that PDTC is a potent inducer of Nrf2 signaling specifically in astrocytes and demonstrate the critical role of Nrf2 in PDTC-mediated protection against oxidative stress. This induction appears to be regulated by both Keap1 and glycogen synthase kinase 3β. Furthermore, the presence of amyloid-beta magnifies PDTC-mediated induction of endogenous protective mechanisms, therefore suggesting that PDTC may be an effective Nrf2 inducer in the context of Alzheimer’s disease. Finally, we show that PDTC increases brain copper content and glial expression of heme oxygenase-1, and decreases lipid peroxidation in vivo, promoting a more antioxidative environment. CONCLUSIONS: PDTC activates Nrf2 and its antioxidative targets in astrocytes but not neurons. These effects may contribute to the neuroprotection observed for PDTC in models of Alzheimer’s disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0515-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-02-26 /pmc/articles/PMC4768425/ /pubmed/26920699 http://dx.doi.org/10.1186/s12974-016-0515-9 Text en © Liddell et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Liddell, Jeffrey R.
Lehtonen, Sarka
Duncan, Clare
Keksa-Goldsteine, Velta
Levonen, Anna-Liisa
Goldsteins, Gundars
Malm, Tarja
White, Anthony R.
Koistinaho, Jari
Kanninen, Katja M.
Pyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes
title Pyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes
title_full Pyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes
title_fullStr Pyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes
title_full_unstemmed Pyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes
title_short Pyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes
title_sort pyrrolidine dithiocarbamate activates the nrf2 pathway in astrocytes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768425/
https://www.ncbi.nlm.nih.gov/pubmed/26920699
http://dx.doi.org/10.1186/s12974-016-0515-9
work_keys_str_mv AT liddelljeffreyr pyrrolidinedithiocarbamateactivatesthenrf2pathwayinastrocytes
AT lehtonensarka pyrrolidinedithiocarbamateactivatesthenrf2pathwayinastrocytes
AT duncanclare pyrrolidinedithiocarbamateactivatesthenrf2pathwayinastrocytes
AT keksagoldsteinevelta pyrrolidinedithiocarbamateactivatesthenrf2pathwayinastrocytes
AT levonenannaliisa pyrrolidinedithiocarbamateactivatesthenrf2pathwayinastrocytes
AT goldsteinsgundars pyrrolidinedithiocarbamateactivatesthenrf2pathwayinastrocytes
AT malmtarja pyrrolidinedithiocarbamateactivatesthenrf2pathwayinastrocytes
AT whiteanthonyr pyrrolidinedithiocarbamateactivatesthenrf2pathwayinastrocytes
AT koistinahojari pyrrolidinedithiocarbamateactivatesthenrf2pathwayinastrocytes
AT kanninenkatjam pyrrolidinedithiocarbamateactivatesthenrf2pathwayinastrocytes